Heritability of urinary traits that contribute to nephrolithiasis
- PMID: 24578335
- PMCID: PMC4011445
- DOI: 10.2215/CJN.08210813
Heritability of urinary traits that contribute to nephrolithiasis
Abstract
Background and objectives: Kidney stones and their risk factors aggregate in families, yet few studies have systematically estimated heritabilities and genetic correlations of the numerous urinary traits associated with risk of kidney stones.
Design, setting, participants, & measurements: Twenty-four-hour urine samples were collected from the Genetic Epidemiology Network of Arteriopathy cohort of families in Rochester, Minnesota, to measure urinary determinants of supersaturation. Diet was assessed using the Viocare food frequency questionnaire. Heritabilities and genetic correlations among the urinary traits were estimated using variance components methods.
Results: Samples were available from 811 individuals (344 men, 467 women; mean age 66 ± 9 years). Age, sex, and weight were significantly correlated with the majority of urinary traits. Many urine excretions (calcium, magnesium, citrate excretion) had strong evidence for heritability (P<0.01) both before and after adjusting for the identified covariates. Among significantly heritable urinary traits, genetic factors explained 20%-36% of interindividual variation after adjustment for covariates. Urinary calcium excretion was significantly genetically correlated with urinary magnesium and with urinary citrate excretion (P<0.05). Although eGFR influenced many urinary traits, controlling for eGFR did not greatly affect estimated heritabilities.
Conclusions: Evidence from this cohort suggests a strong heritable component to many urinary nephrolithiasis risk factors. Further study of genetic influences on urinary traits relevant for kidney stone pathogenesis is warranted.
References
-
- Parks JH, Coward M, Coe FL: Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 51: 894–900, 1997 - PubMed
-
- Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y: Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study. Hypertension 45: 198–202, 2005 - PubMed
-
- Daniels PR, Kardia SL, Hanis CL, Brown CA, Hutchinson R, Boerwinkle E, Turner ST, Genetic Epidemiology Network of Arteriopathy study : Familial aggregation of hypertension treatment and control in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Am J Med 116: 676–681, 2004 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01-DK077950/DK/NIDDK NIH HHS/United States
- R01-HL087660/HL/NHLBI NIH HHS/United States
- R01 HL087660/HL/NHLBI NIH HHS/United States
- P50-DK083007/DK/NIDDK NIH HHS/United States
- R01 DK077950/DK/NIDDK NIH HHS/United States
- P50 DK083007/DK/NIDDK NIH HHS/United States
- U54 DK100227/DK/NIDDK NIH HHS/United States
- R01 DK073537/DK/NIDDK NIH HHS/United States
- U01 HL054457/HL/NHLBI NIH HHS/United States
- UL1 TR000135/TR/NCATS NIH HHS/United States
- UL1-TR000135/TR/NCATS NIH HHS/United States
- U01-HL054457/HL/NHLBI NIH HHS/United States
- R01-DK073537/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
